Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wildgoose, P.
Right arrow Articles by Hedner, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wildgoose, P.
Right arrow Articles by Hedner, U.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Measurement of basal levels of factor VIIa in hemophilia A and B patients [see comments]

P Wildgoose, Y Nemerson, LL Hansen, FE Nielsen, S Glazer and U Hedner

Novo Nordisk A/S, Biopharmaceuticals Division, Gentofte, Denmark.

Previous results, presented in abstract form, indicate that replacement of thromboplastin with a mixture of phospholipid and truncated soluble tissue factor apoprotein results in a coagulation assay that can directly measure plasma factor VIIa levels without interference from zymogen factor VII (Atherosclerosis Thromb 11:1544a, 1991 [abstr]). We have exploited the specificity and sensitivity of such a factor VIIa specific coagulation assay to directly assess the in vivo relationship of factor VIII and factor IX on the production of factor VIIa levels under nonthrombotic and nonstimulatory conditions. Normal individuals (n = 20) were found to possess an average circulating factor VIIa level corresponding to 4.34 +/- 1.57 ng/mL, or approximately 1% of their total factor VII antigen. Severe factor VIII deficient patients (n = 13) possessed a slightly lower but statistically significant (P less than .01) decrease in their basal factor VIIa levels (2.69 +/- 1.52 ng/mL), corresponding to approximately 60% of that observed in normal individuals. On the other hand, severe factor IX deficient patients (n = 7) were found to possess even lower levels of factor VIIa corresponding to 0.33 +/- 0.15 ng/mL, or less than 10% of that observed in normal individuals. Measurement of total factor VII antigen levels shows that the variation in basal factor VIIa levels stems from differences in the degree of factor VII activation as opposed to differences in factor VII antigen levels. Our present data are consistent with the hypothesis that factor IXa is the principal in vivo activator of factor VII under basal conditions.

Volume 80, Issue 1, pp. 25-28, 07/01/1992
Copyright © 1992 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
TraumaHome page
U. Hedner and M. Ezban
Recent advances in clot biology and assessment of clotting
Trauma, October 1, 2008; 10(4): 261 - 270.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. V. M. Rao and U. R. Pendurthi
Tissue Factor-Factor VIIa Signaling
Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 47 - 56.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Tranholm, K. Kristensen, A. T. Kristensen, C. Pyke, R. Rojkjaer, and E. Persson
Improved hemostasis with superactive analogs of factor VIIa in a mouse model of hemophilia A
Blood, November 15, 2003; 102(10): 3615 - 3620.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. van 't Veer, N. J. Golden, and K. G. Mann
Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa
Blood, February 15, 2000; 95(4): 1330 - 1335.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. M. van 't Hooft, A. Silveira, P. Tornvall, A. Iliadou, E. Ehrenborg, P. Eriksson, and A. Hamsten
Two Common Functional Polymorphisms in the Promoter Region of the Coagulation Factor VII Gene Determining Plasma Factor VII Activity and Mass Concentration
Blood, May 15, 1999; 93(10): 3432 - 3441.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. P. Wamala, M. A. Murray, M. Horsten, M. Eriksson, K. Schenck-Gustafsson, A. Hamsten, A. Silveira, and K. Orth-Gomer
Socioeconomic Status and Determinants of Hemostatic Function in Healthy Women
Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 485 - 492.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Philippou, S. J. Davidson, M. T. Mole, J. R. Pepper, J. F. Burman, and D. A. Lane
Two-Chain Factor VIIa Generated in the Pericardium During Surgery With Cardiopulmonary Bypass : Relationship to Increased Thrombin Generation and Heparin Concentration
Arterioscler. Thromb. Vasc. Biol., February 1, 1999; 19(2): 248 - 254.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. S. Key, A. Slungaard, L. Dandelet, S. C. Nelson, C. Moertel, L. A. Styles, F. A. Kuypers, and R. R. Bach
Whole Blood Tissue Factor Procoagulant Activity Is Elevated in Patients With Sickle Cell Disease
Blood, June 1, 1998; 91(11): 4216 - 4223.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
U. Orvim, R. M. Barstad, L. Orning, L. B. Petersen, M. Ezban, U. Hedner, and K. S. Sakariassen
Antithrombotic Efficacy of Inactivated Active Site Recombinant Factor VIIa Is Shear Dependent in Human Blood
Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3049 - 3056.
[Abstract] [Full Text]


Home page
BloodHome page
M. Cugno, M. Cicardi, B. Bottasso, R. Coppola, R. Paonessa, P. M. Mannucci, and A. Agostoni
Activation of the Coagulation Cascade in C1-Inhibitor Deficiencies
Blood, May 1, 1997; 89(9): 3213 - 3218.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Philippou, A. Adami, R. A. Amersey, P. J. Stubbs, and D. A. Lane
A Novel Specific Immunoassay for Plasma Two-Chain Factor VIIa: Investigation of FVIIa Levels in Normal Individuals and in Patients With Acute Coronary Syndromes
Blood, February 1, 1997; 89(3): 767 - 775.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Kapur, C. J. Hoffman, V. Bhushan, and M. B. Hultin
Postprandial Elevation of Activated Factor VII in Young Adults
Arterioscler. Thromb. Vasc. Biol., November 1, 1996; 16(11): 1327 - 1332.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Silveira, F. Karpe, H. Johnsson, K. A. Bauer, and A. Hamsten
In Vivo Demonstration in Humans That Large Postprandial Triglyceride-Rich Lipoproteins Activate Coagulation Factor VII Through the Intrinsic Coagulation Pathway
Arterioscler. Thromb. Vasc. Biol., November 1, 1996; 16(11): 1333 - 1339.
[Abstract] [Full Text]


Home page
CirculationHome page
J. H. Chung, N. Gikakis, A. K. Rao, T. A. Drake, R. W. Colman, and L. H. Edmunds Jr
Pericardial Blood Activates the Extrinsic Coagulation Pathway During Clinical Cardiopulmonary Bypass
Circulation, June 1, 1996; 93(11): 2014 - 2018.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Kario, T. Matsuo, H. Kobayashi, M. Matsuo, T. Sakata, T. Miyata, and K. Shimada
Factor VII Hyperactivity and Endothelial Cell Damage Are Found in Elderly Hypertensives Only When Concomitant With Microalbuminuria
Arterioscler. Thromb. Vasc. Biol., March 1, 1996; 16(3): 455 - 461.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Zitoun, L. Bara, A. Basdevant, and M. M. Samama
Levels of Factor VIIc Associated With Decreased Tissue Factor Pathway Inhibitor and Increased Plasminogen Activator Inhibitor-1 in Dyslipidemias
Arterioscler. Thromb. Vasc. Biol., January 1, 1996; 16(1): 77 - 81.
[Abstract] [Full Text]


Home page
CirculationHome page
Y. Jang, L. A. Guzman, A. M. Lincoff, M. Gottsauner-Wolf, F. Forudi, C. E. Hart, D. W. Courtman, M. Ezban, S. G. Ellis, and E. J. Topol
Influence of Blockade at Specific Levels of the Coagulation Cascade on Restenosis in a Rabbit Atherosclerotic Femoral Artery Injury Model
Circulation, November 15, 1995; 92(10): 3041 - 3050.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. A. Merlini, D. Ardissino, L. Oltrona, M. Broccolino, R. Coppola, and P. M. Mannucci
Heightened Thrombin Formation but Normal Plasma Levels of Activated Factor VII in Patients With Acute Coronary Syndromes
Arterioscler. Thromb. Vasc. Biol., October 1, 1995; 15(10): 1675 - 1679.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Kario, T. Matsuo, H. Kobayashi, M. Matsuo, T. Sakata, and T. Miyata
Activation of Tissue Factor–Induced Coagulation and Endothelial Cell Dysfunction in Non–Insulin-Dependent Diabetic Patients With Microalbuminuria
Arterioscler. Thromb. Vasc. Biol., August 1, 1995; 15(8): 1114 - 1120.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. Moor, A. Silveira, F. van't Hooft, A. M. Suontaka, P. Eriksson, M. Blomback, and A. Hamsten
Coagulation Factor VII Mass and Activity in Young Men With Myocardial Infarction at a Young Age : Role of Plasma Lipoproteins and Factor VII Genotype
Arterioscler. Thromb. Vasc. Biol., May 1, 1995; 15(5): 655 - 664.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Sakata, K. Kario, T. Matsuo, Y. Katayama, T. Matsuyama, H. Kato, and T. Miyata
Suppression of Plasma-Activated Factor VII Levels by Warfarin Therapy
Arterioscler. Thromb. Vasc. Biol., February 1, 1995; 15(2): 241 - 246.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Y. Kazama, T. Hamamoto, D. C. Foster, and W. Kisiel
Hepsin, a Putative Membrane-associated Serine Protease, Activates Human Factor VII and Initiates a Pathway of Blood Coagulation on the Cell Surface Leading to Thrombin Formation
J. Biol. Chem., January 6, 1995; 270(1): 66 - 72.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. J. Warn-Cramer and S. I. Rapaport
Evidence Suggestive of Activation of the Intrinsic Pathway of Blood Coagulation After Injection of Factor Xa/Phospholipid Into Rabbits
Arterioscler. Thromb. Vasc. Biol., January 1, 1995; 15(1): 133 - 139.
[Abstract] [Full Text]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1992 by American Society of Hematology         Online ISSN: 1528-0020